StonvexLoading…
StonvexStonvexStonvexCore line items from IRDM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $225.21M | $219.06M | $871.66M | $658.72M | $431.78M |
Operating Income | Not available | $50.71M | $235.98M | $180.73M | $110.65M |
Net Income | Not available | $21.59M | $114.37M | $89.51M | $52.38M |
EPS (Diluted) | $0.28 | $0.20 | $1.06 | $0.82 | $0.48 |
Total Assets | Not available | $2.53B | $2.53B | $2.55B | $2.57B |
Total Liabilities | Not available | $2.06B | $2.07B | $2.10B | $2.09B |
Cash & Equivalents | Not available | $111.64M | $96.50M | $88.53M | $79.31M |
Free Cash Flow OCF − CapEx | Not available | $41.66M | $299.79M | $224.69M | $145.44M |
Shares Outstanding | Not available | 106.56M | 107.84M | 108.85M | 109.50M |